Table 1.
Patient Demographics. Figures are Median (interquartile range) or Number (percentage). CCG—clinical Commissioning Groups, Effectively Geographic Areas Containing Several Primary Care Practices
| Cabergoline | P value | ||
|---|---|---|---|
| Yes (n = 646) | No (n = 2660) | ||
| Age (years) | 41 (34-49) | 42 (35-51) | 0.004 |
| Gender | |||
| Female | 542 (84%) | 2246 (84%) | 0.763 |
| Male | 104 (16%) | 414 (16%) | |
| Ethnicity | |||
| Asian/Asian British | 126 (20%) | 510 (19%) | 0.048 |
| Black/Black British | 213 (33%) | 796 (30%) | |
| Mixed | 20 (3.1%) | 44 (1.7%) | |
| Unknown | 70 (11%) | 303 (11%) | |
| White | 217 (34%) | 1007 (38%) | |
| CCG | |||
| City and Hackney | 153 (24%) | 597 (22%) | 0.917 |
| Newham | 202 (31%) | 835 (31%) | |
| Tower Hamlets | 136 (21%) | 579 (22%) | |
| Waltham Forest | 155 (24%) | 649 (24%) | |
| Diabetes | 36 (5.6%) | 67 (2.5%) | <0.001 |
| Hypertension | 83 (13%) | 203 (7.6%) | <0.001 |
| IHD | 6 (0.9%) | 0 (0%) | <0.001 |
| Smoking status | |||
| Smoker | 169 (26%) | 1101 (41%) | <0.001 |
| Never smoked | 350 (54%) | 1492 (56%) | |
| Unknown | 127 (20%) | 67 (2.5%) | |
| Cumulative cabergoline dose (mg) | 56 (27-123) | - | - |
| Duration of cabergoline use (months) | 27 (15-46) | - | - |
| Cardiac complications | 18 (2.8%) | 52 (2.0%) | 0.221 |
Figures are median (interquartile range) or number (percentage).
Abbreviations: CCG, Clinical Commissioning Groups (effectively geographic areas containing several primary care practices); IHD, ischemic heart disease.